// App-Quantinova.ai

1573 : The progesterone analogue, Norgestrel, impairs tumor immunity and promotes metastatic breast cancer progression

Researchers

Presenter

  • Tomas Dalotto Moreno

Principal Investigators

  • Gabriel Adrian Rabinovich

  • Mariana Salatino

Medical Centers

  • Institute of Biology and Experimental Medicine, CONICET, Vuelta de Obligado, Argentina.

Locations

  • Argentina

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Cluster of Differentiation 25

  • Cluster of Differentiation 4

  • Cluster of Differentiation 44

  • Cluster of differentiation 8A

  • Receptor activator of nuclear factor kappa-Β ligand

  • Serine/threonine-protein kinase mTOR

  • Regulatory T cells

Drug/Treatment

  • Norgestrel

  • Progestin

  • CycloGest

  • Lonaprisan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved